← Eichor
Study identifier: NCT06541587 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Smart VR Mindfulness for Breast Cancer: Integrating Biofeedback and Evaluating Chemotherapy Effectiveness

Condition: Breast Cancer · Chemotherapy · Virtual Reality  ·  Sponsor: Hsin Yi Lu

PhaseNA
Planned participants60
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Breast cancer patients undergoing chemotherapy often face significant physical and emotional symptoms, with stress contributing to symptom severity. This study investigates the effectiveness of a mindfulness-based virtual reality (VR) intervention in reducing stress and symptom severity. A total of 60 participants will be stratified and randomized into three groups: mindfulness-based VR, mindfulness-based audio, and control. Data will be analyzed using generalized estimating equations and machine learning. The goal is to improve understanding and quality of care for cancer patients by evaluating the potential benefits of mindfulness-based VR interventions.

This description comes directly from the study's public registry record.

Talk to the study team

Hsin-Yi Lu  ·  +886972221359  ·  f8888877@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tri-Service General HospitalTaipei, Neihu Distinct, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06541587